Schedule of Stock Options Roll Forward (Details) - Equity Option [Member] - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|||||||||||
Marketable Securities [Line Items] | ||||||||||||
Options Shares Outstanding, Beginning | 994,500 | 1,018,400 | ||||||||||
Options Weighted Average Exercise Price Outstanding, Beginning | $ 5.57 | $ 5.02 | ||||||||||
Options Aggregate Intrinsic Value Outstanding, Beginning | [1] | |||||||||||
Options Shares, Granted | 45,000 | 295,000 | ||||||||||
Options Weighted Average Exercise Price, Granted | $ 7.75 | $ 3.95 | ||||||||||
Options Shares, Exercised | (43,500) | (44,400) | ||||||||||
Options Weighted Average Exercise Price, Exercised | $ 5.61 | $ 3.56 | ||||||||||
Options Aggregate Intrinsic Value, Exercised | $ 212,410 | [2] | $ 370,196 | [1] | ||||||||
Options Shares, Forfeited/expired | (11,000) | (4,500) | ||||||||||
Options Weighted Average Exercise Price, Forfeited/expired | $ 7.01 | $ 3.90 | ||||||||||
Options Shares Outstanding, Ending | 985,000 | [3] | 1,264,500 | [4] | ||||||||
Options Weighted Average Exercise Price Outstanding, Ending | $ 5.66 | [3] | $ 4.83 | [4] | ||||||||
Options Weighted Average Remaining Contractual Term (years) Outstanding | 4 years 9 months 18 days | [3] | 4 years 2 months 12 days | [4] | ||||||||
Options Aggregate Intrinsic Value Outstanding, Ending | $ 6,139,346 | [2],[3] | $ 8,791,279 | [1],[4] | ||||||||
Options Shares, Exercisable | 350,300 | [2] | 499,500 | [4] | ||||||||
Options Weighted Average Exercise Price, Exercisable | $ 5.06 | [2] | $ 4.30 | [4] | ||||||||
Options Weighted Average Remaining Contractual Term (years) Exercisable | 3 years 9 months 18 days | [2] | 2 years 3 months 18 days | [4] | ||||||||
Options Aggregate Intrinsic Value, Exercisable | [1] | $ 2,391,576 | [2] | $ 6,047,029 | [4] | |||||||
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Weighted average price of options that were either forfeited or expired. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|